VIVO.V - VIVO Cannabis Inc.

TSXV - TSXV Delayed Price. Currency in CAD
0.2400
0.0000 (0.00%)
As of 1:59PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close0.2400
Open0.2400
Bid0.2350 x 0
Ask0.2400 x 0
Day's Range0.2350 - 0.2400
52 Week Range0.2250 - 1.2200
Volume71,828
Avg. Volume309,164
Market Cap70.999M
Beta (3Y Monthly)3.09
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • VIVO Cannabis™ Reports Third Quarter 2019 Results
    CNW Group

    VIVO Cannabis™ Reports Third Quarter 2019 Results

    Received conditional approval to graduate from the TSX Venture Exchange (the "TSXV") and list common shares on the Toronto Stock Exchange (the "TSX"). Completed first harvest at the new 86,000 square foot Kimmetts airhouse facility in Napanee, Ontario , following the issuance of a standard cultivation licence by Health Canada in August 2019 . Received a licence amendment to begin selling cannabis edibles, concentrates and topicals, with sales of premium cannabis chocolates, bubble hash, rosin, shatter, wax, vape pens and cartridges expected to commence in Ontario and other Canadian markets later this year or early in 2020.

  • VIVO Cannabis Receives Conditional Approval to Graduate to the Toronto Stock Exchange
    CNW Group

    VIVO Cannabis Receives Conditional Approval to Graduate to the Toronto Stock Exchange

    NAPANEE, ON , Nov. 12, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that it has received conditional approval from the Toronto Stock Exchange (the "TSX") to graduate from the TSX Venture Exchange (the "TSXV") and list its common shares on the TSX.

  • VIVO Cannabis to Host Third Quarter 2019 Financial Results Conference Call
    CNW Group

    VIVO Cannabis to Host Third Quarter 2019 Financial Results Conference Call

    VIVO Cannabis to Host Third Quarter 2019 Financial Results Conference Call

  • VIVO and CB2 Insights Enter Technology and Research Partnership
    CNW Group

    VIVO and CB2 Insights Enter Technology and Research Partnership

    OTCQB: CBIIF) ("CB2"), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, announced it has entered into a technology and multi-phase research agreement with VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO"), an Ontario -based cannabis company recognized for its premium products and services, to assist in the development of VIVO's global medical product development strategy. Under the terms of the agreement, CB2 will be integrating CB2's Clinical Data Management Software (CDMS) and Electronic Data Capture (EDC) tools to establish better understanding of VIVO's current medical patient registry.

  • VIVO Cannabis™ Reaffirms Timing of First Harvest at Kimmetts and Additional 2020 Cultivation Plans
    CNW Group

    VIVO Cannabis™ Reaffirms Timing of First Harvest at Kimmetts and Additional 2020 Cultivation Plans

    NAPANEE, ON , Oct. 3, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced it expects to commence first harvest at its Kimmetts facility in Napanee, Ontario in the fourth quarter of 2019. VIVO also unveiled its 2020 plans for the facility, which include an accelerated planting schedule and the contemplated use of five additional acres of land adjacent to the existing airhouses. The announcements were made during VIVO's analyst and investor day held in Napanee , where the Company showcased its airhouse technology, extraction programs and progress towards achieving EU GMP certification.

  • Cannabis Growth Opportunity Corporation Announces NAV of $2.85
    CNW Group

    Cannabis Growth Opportunity Corporation Announces NAV of $2.85

    TORONTO , Sept. 19, 2019 /CNW/ - Cannabis Growth Opportunity Corporation ("CGOC", or the "Company") (CSE: CGOC), a cannabis-focused investment corporation with both public and private cannabis holdings, announces the company's updated net asset value per common share ("NAV") of $2.85 at the close of business on September 16, 2019 . This represents growth of 23% since the Initial Public Offering ("IPO"), on January 26, 2018 , and 3% year to date. CGOC's top ten public investments as of September 16, 2019 (in alphabetical order) are: Bhang Inc (CSE:BHNG), Grassroots Cannabis, (not yet listed), Heritage Cannabis (CSE:CANN), Jushi Holdings Inc. (NEO:JUSH.B), LPF Investment Corp. ("Loudpack", not yet listed) Next Green Wave (CSE:NGW), Planet 13 Holdings Inc. (CSE:PLTH), TerrAscend Corp. (CSE:TER), and VIVO Cannabis (VIVO.V).

  • VIVO Cannabis™ Partners with Linneo Health to Supply Medical Cannabis in Europe
    CNW Group

    VIVO Cannabis™ Partners with Linneo Health to Supply Medical Cannabis in Europe

    NAPANEE, ON , Sept. 17, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced it has partnered with Linneo Health S.L. ("Linneo Health"), a subsidiary of Alcaliber S.A., to be its European medical cannabis supply partner. Linneo Health, a European leader in the pharmaceutical cannabis industry, recently received its EU-GMP (Good Manufacturing Practices) certification from the Spanish regulatory authorities. "Our partnership with Linneo Health is part of our strategic priority to accelerate international market growth," said Barry Fishman , Chief Executive Officer of VIVO.

  • VIVO Cannabis™ Reports Q2 2019 Financial and Operating Results
    CNW Group

    VIVO Cannabis™ Reports Q2 2019 Financial and Operating Results

    Health Canada approval was received to begin extraction operations using VIVO's on-site CO2 extraction system at the Napanee facility, and the Company has procured an ethanol system that will bring total extraction capacity to 50,000 kilograms per year. NAPANEE, ON , Aug. 28, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), today released its second quarter 2019 financial and operating results. "We remain focused on increasing long-term shareholder value by continuing to establish ourselves as a premium provider of cannabis products and services.

  • Cannabis Growth Opportunity Corporation Announces NAV of $2.96
    CNW Group

    Cannabis Growth Opportunity Corporation Announces NAV of $2.96

    Cannabis Growth Opportunity Corporation Announces NAV of $2.96

  • VIVO Cannabis to Host Second Quarter 2019 Financial Results Conference Call
    CNW Group

    VIVO Cannabis to Host Second Quarter 2019 Financial Results Conference Call

    VIVO Cannabis to Host Second Quarter 2019 Financial Results Conference Call

  • PR Newswire

    The Cannabis ETF (THCX) Rebalance Further Diversifies Portfolio

    THCX Adds Companies Focused on CBD, Ancillary Services and Canadian Retail Market NEW YORK , Aug. 13, 2019 /PRNewswire/ -- Innovation Shares, a provider of thematic ETFs, announced it has completed the ...

  • VIVO Announces 50% Increase in Licensed Capacity and Third Licensed Site with New Innovative Seasonal Greenhouses
    CNW Group

    VIVO Announces 50% Increase in Licensed Capacity and Third Licensed Site with New Innovative Seasonal Greenhouses

    NAPANEE, ON , Aug. 6, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that the Company's wholly-owned subsidiary, ABcann Medicinals Inc., has been granted a Standard Cultivation licence from Health Canada for its Kimmetts facility. Kimmetts, an innovative seasonal greenhouse site in Napanee, Ontario , is VIVO's third licensed production facility. The new site will increase the Company's annualized cultivation capacity by 4,000 kilograms, bringing its total internal licensed capacity to over 12,000 kilograms.

  • VIVO Commences Extraction Operations in Napanee, Ontario
    CNW Group

    VIVO Commences Extraction Operations in Napanee, Ontario

    "We are extremely excited to commence CO2 extraction operations at our Napanee facility," said Gary McMullen , Vice-President, Napanee Operations. Upon receipt of EU-GMP certification for its Napanee facility, the Company is expected to be able to ship extracted cannabis products to Europe and other countries for scientific and medical purposes, subject to receipt of all necessary import and export permits, in addition to selling domestically.

  • Cannabis Growth Opportunity Corporation Announces NAV of $3.11
    CNW Group

    Cannabis Growth Opportunity Corporation Announces NAV of $3.11

    Cannabis Growth Opportunity Corporation Announces NAV of $3.11

  • VIVO Announces Strategic Investment in Friendly Stranger
    CNW Group

    VIVO Announces Strategic Investment in Friendly Stranger

    NAPANEE, ON , June 20, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that it has made a $1.25 million strategic investment in Friendly Stranger Holdings Corp. ("Friendly Stranger"), a longstanding retail champion of cannabis culture. "VIVO is focused on expanding capacity and increasing production capability to help meet the growing demand for cannabis among recreational users," stated Barry Fishman , Chief Executive Officer of VIVO. "Friendly Stranger has been an iconic brand in the Canadian cannabis sector for more than 25 years and we believe trusted retailers are integral to showcasing our premium family of brands, including Canna Farms™, Fireside™, and Lumina™.

  • Cannabis Growth Opportunity Corporation Announces NAV of $3.27
    CNW Group

    Cannabis Growth Opportunity Corporation Announces NAV of $3.27

    Cannabis Growth Opportunity Corporation Announces NAV of $3.27

  • VIVO Completes First Canadian Installation of Innovative Airhouses in Napanee
    CNW Group

    VIVO Completes First Canadian Installation of Innovative Airhouses in Napanee

    NAPANEE, ON , June 12, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") today announced that the Company's wholly-owned subsidiary, ABcann Medicinals Inc., has received notification that its Kimmetts project has now advanced to the second phase of Health Canada's review and approval process. Kimmetts is being developed as a hybrid outdoor cultivation site, which currently houses four Airstream InnovationsTM environmental control shelters with 86,000 square feet of cultivation space. "Our airhouses are expected to capitalize on all the benefits and opportunities associated with growing outdoors (low capital and production costs, environmentally sustainable) with the added benefit of mitigating against the known challenges of producing high-quality cannabis outdoors," said Greg Yuristy , Director of Production for Napanee Operations.

  • VIVO Cannabis™ Reports Results of 2019 AGM
    CNW Group

    VIVO Cannabis™ Reports Results of 2019 AGM

    NAPANEE, ON , June 5, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services for the medical and adult-use markets and licensed producer of cannabis under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited and ABcann Medicinals Inc., and its medical cannabis clinic network operated by Harvest Medicine Inc., today announced the results of its annual general and special meeting of shareholders held on June 4, 2019 (the "Meeting").

  • VIVO Cannabis™ Reports Q1 2019 Financial Results
    CNW Group

    VIVO Cannabis™ Reports Q1 2019 Financial Results

    NAPANEE, ON , May 29, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services for the medical and adult-use markets and licensed producer of cannabis under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), and its medical cannabis clinic network operated by Harvest Medicine Inc. ("Harvest Medicine"), today released its Q1 2019 financial and operating results. "The first half of 2019 has been focused on increasing VIVO's production capacity. With the recent doubling of capacity at both our Canna Farms and Vanluven facilities, we have been very successful in that regard," said Barry Fishman , President and Chief Executive Officer of VIVO.

  • VIVO Cannabis Signs Australian Distribution Agreement
    CNW Group

    VIVO Cannabis Signs Australian Distribution Agreement

    NAPANEE, ON , May 22, 2019 /CNW/ - VIVO Cannabis Inc. (TSXV: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company") is pleased to announce that it has signed a distribution agreement with Burleigh Heads Cannabis Pty Ltd. (" Burleigh Heads "), one of Australia's leading medicinal cannabis distributors. The agreement is expected to increase the ability of Australian patients to access VIVO's high-quality medicinal cannabis flower, oil and other products via approved channels. The required regulatory import permits necessary to enable the first shipment of product under the agreement have been granted by the Australia Office of Drug Control, and Burleigh Heads expects to import the first shipment of VIVO products in June, subject to receipt of a Canadian export permit.

  • Vivo Cannabis™ to report Q1 2019 results on May 29, 2019
    CNW Group

    Vivo Cannabis™ to report Q1 2019 results on May 29, 2019

    Vivo Cannabis™ to report Q1 2019 results on May 29, 2019

  • VIVO Adds New Craft Producer GTEC Holdings Inc. and Additional Pure Sun Farms Products to On-Line Medical Cannabis Platform
    CNW Group

    VIVO Adds New Craft Producer GTEC Holdings Inc. and Additional Pure Sun Farms Products to On-Line Medical Cannabis Platform

    VIVO Adds New Craft Producer GTEC Holdings Inc. and Additional Pure Sun Farms Products to On-Line Medical Cannabis Platform

  • Cannabis Growth Opportunity Corporation Announces NAV of $3.41
    CNW Group

    Cannabis Growth Opportunity Corporation Announces NAV of $3.41

    Cannabis Growth Opportunity Corporation Announces NAV of $3.41

  • CNW Group

    Canna Farms Expands Sales to Alberta

    HOPE, BC , May 10, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) ("VIVO" or the "Company") is pleased to announce that its wholly-owned subsidiary, Canna Farms Limited ("Canna Farms"), has completed registration with Alberta Gaming, Liquor & Cannabis ("AGLC") to supply the Province of Alberta with its well-recognized premium cannabis products. Canna Farms is preparing its first shipments for immediate delivery to AGLC. "We are very excited to bring our premium products to the Alberta consumer market, one of the strongest in Canada , and fill some of the current industry supply gaps while continuing to expand our distribution channels," said Daniel Laflamme , President of Canna Farms.

  • VIVO Cannabis™ announces significant revenue growth for 2018
    CNW Group

    VIVO Cannabis™ announces significant revenue growth for 2018

    NAPANEE, ON , April 30, 2019 /CNW/ - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services for the medical and adult-use markets and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms"), ABcann Medicinals Inc. ("ABcann") and Harvest Medicine Inc. ("Harvest Medicine"), today announced the release of its fourth quarter and 2018 annual financial and operating results. "The VIVO team achieved significant milestones in 2018, leading to substantial increases in net revenue, cash position, production capacity, organizational effectiveness and customer development," said Barry Fishman , Chief Executive Officer of VIVO.